The efficacy of proton pump inhibitors in nonulcer dyspepsia: A systematic review and economic analysis

Chiba, 1997, Speed of healing and symptom relief in grade II to IV gastroesophageal reflux disease, Gastroenterology, 112, 1798, 10.1053/gast.1997.v112.pm9178669 Tebaldi, 1998, Clinical economics review, Aliment Pharmacol Ther, 12, 11, 10.1046/j.1365-2036.1998.00261.x Delaney, 2003 Talley, 1995, Review article, Aliment Pharmacol Ther, 9, 107, 10.1111/j.1365-2036.1995.tb00359.x Farup, 2002, Functional dyspepsia and gastric acid, Scand J Gastroenterol, 37, 1349, 10.1080/003655202762671198 Talley, 1998, Efficacy of omeprazole in functional dyspepsia, Aliment Pharmacol Ther, 12, 1055, 10.1046/j.1365-2036.1998.00410.x Wong, 2002, Double blind, randomised, placebo controlled study of four weeks of lansoprazole for the treatment of functional dyspepsia in Chinese patients, Gut, 51, 502, 10.1136/gut.51.4.502 Moayyedi, 2003, Pharmacological interventions for non-ulcer dyspepsia, Cochrane Database Syst Rev, 1, CD001960 Talley, 1991, Functional dyspepsia, Gastroenterol Int, 4, 145 Talley, 1999, Functional gastroduodenal disorders, Gut, 45, II37, 10.1136/gut.45.2008.ii37 1988, Management of dyspepsia, Lancet, 1, 576 Juni, 2001, Assessing the quality of controlled clinical trials, BMJ, 323, 42, 10.1136/bmj.323.7303.42 Juni, 1999, The hazards of scoring the quality of clinical trials for meta-analysis, JAMA, 282, 1054, 10.1001/jama.282.11.1054 DerSimonian, 1986, Meta-analysis in clinical trials, Control Clin Trials, 7, 177, 10.1016/0197-2456(86)90046-2 Begg, 1994, Operating characteristics of a rank correlation test for publication bias, Biometrics, 50, 1088, 10.2307/2533446 Delaney, 2000, Cost-effectiveness of initial endoscopy for dyspepsia in patients over age 50 years, Lancet, 356, 1965, 10.1016/S0140-6736(00)03308-0 Meineche-Schmidt, 1999, Impact of functional dyspepsia on quality of life and health care consumption after cessation of antisecretory treatment. A multicentre 3-month follow-up study, Scand J Gastroenterol, 34, 566, 10.1080/003655299750026010 Dent, 1994, Omeprazole v ranitidine for prevention of relapse in reflux oesophagitis. A controlled double blind trial of their efficacy and safety, Gut, 35, 590, 10.1136/gut.35.5.590 Spiegel, 2002, Dyspepsia management in primary care, Gastroenterology, 122, 1270, 10.1053/gast.2002.33019 Moayyedi, 2002, Clinical and economic consequences of dyspepsia in the community, Gut, 50, iv10, 10.1136/gut.50.suppl_4.iv10 O’Brien, 2002, Analysis of uncertainty in health care cost-effectiveness studies, Stat Methods Med Res, 11, 455, 10.1191/0962280202sm304ra Peura, 2004, Lansoprazole in the treatment of functional dyspepsia, Am J Med, 116, 740, 10.1016/j.amjmed.2004.01.008 Blum, 2000, Short course acid suppressive treatment for patients with functional dyspepsia, Gut, 47, 473, 10.1136/gut.47.4.473 Bolling-Sternevald, 2002, Effect of profound acid suppression in functional dyspepsia, Scand J Gastroenterol, 37, 1395, 10.1080/003655202762671260 Farup, 1999, Patients with functional dyspepsia responding to omeprazole have a characteristic gastro-oesophageal reflux pattern, Scand J Gastroenterol, 34, 575, 10.1080/003655299750026029 Dillon, 2004, A comparison of lansoprazole vs. ranitidine in the treatment of functional ulcer-like dyspepsia as defined by the Rome II criteria, Gut, 53, A285 Kleinman, 2002, Willingness to pay for complete symptom relief of gastroesophageal reflux disease, Arch Intern Med, 162, 1361, 10.1001/archinte.162.12.1361 Samsom, 1999, Abnormal clearance of exogenous acid and increased acid sensitivity of the proximal duodenum in dyspeptic patients, Gastroenterology, 116, 515, 10.1016/S0016-5085(99)70171-X Lee, 2004, Influence of duodenal acidification on the sensorimotor function of the proximal stomach in humans, Am J Physiol, 286, G278 Bates, 1989, Blocked and nonblocked acid secretion and reported pain in ulcer, nonulcer dyspepsia, and normal subjects, Gastroenterology, 97, 376, 10.1016/0016-5085(89)90073-5 Collen, 1989, Basal gastric acid secretion in nonulcer dyspepsia with or without duodenitis, Dig Dis Sci, 34, 246, 10.1007/BF01536059 George, 1991, Sensitivity of the gastric mucosa to acid and duodenal contents in patients with nonulcer dyspepsia, Gastroenterology, 101, 3, 10.1016/0016-5085(91)90453-R Nyren, 2002, Functional dyspepsia, Gut, 51, 464, 10.1136/gut.51.4.464 Meineche-Schmidt, 2000, Which dyspepsia patients will benefit from omeprazole treatment? Analysis of a Danish multicenter trial, Am J Gastroenterol, 95, 2777 Bolling-Sternevald, 2003, Is it possible to predict treatment response to a proton pump inhibitor in functional dyspepsia?, Aliment Pharmacol Ther, 18, 117, 10.1046/j.1365-2036.2003.01651.x Bytzer, 2000, Identifying responders to acid suppression in dyspepsia using a random starting day trial, Aliment Pharmacol Ther, 14, 1485, 10.1046/j.1365-2036.2000.00866.x Moayyedi, 2003, Systematic review, Aliment Pharmacol Ther, 17, 1215, 10.1046/j.1365-2036.2003.01575.x Moayyedi, 2003, An update of the Cochrane systematic review of Helicobacter pylori eradication in nonulcer dyspepsia, Am J Gastroenterol, 98, 2621, 10.1111/j.1572-0241.2003.08724.x Gillen, 1999, Helicobacter pylori infection potentiates the inhibition of gastric acid secretion by omeprazole, Gut, 44, 468, 10.1136/gut.44.4.468 Moayyedi, 2000, Systematic review and economic evaluation of Helicobacter pylori eradication treatment for non-ulcer dyspepsia, BMJ, 321, 659, 10.1136/bmj.321.7262.659 Carlsson, 1998, The usefulness of a structured questionnaire in the assessment of symptomatic gastroesophageal reflux disease, Scand J Gastroenterol, 33, 1023, 10.1080/003655298750026697